Oskira-2: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study Of 2 Dosing Regimens Of Fostamatinib In Rheumatoid Arthritis Patients With An Inadequate Response To Disease-Modifying Antirheumatic Drugs.

Dawes, Peter; Dimic, Aleksandar N; Genovese, Mark C; van, der Heijde Desiree; Jenkins, Martin; O'Brien, Chris; Oemar, Barry; Vencovsky, Jiri; Weinblatt, Michael

Rezultati

eNauka > Rezultati > Oskira-2: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study Of 2 Dosing Regimens Of Fostamatinib In Rheumatoid Arthritis Patients With An Inadequate Response To Disease-Modifying Antirheumatic Drugs.

Naziv:	Oskira-2: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study Of 2 Dosing Regimens Of Fostamatinib In Rheumatoid Arthritis Patients With An Inadequate Response To Disease-Modifying Antirheumatic Drugs.
Autori:	Dawes, Peter; Dimic, Aleksandar N; Genovese, Mark C; van, der Heijde Desiree; Jenkins, Martin; O'Brien, Chris; Oemar, Barry; Vencovsky, Jiri; Weinblatt, Michael
Godina:	2013
Publikacija:	ARTHRITIS AND RHEUMATISM
ISSN:	0004-3591 Arthritis and Rheumatism Pretraži identifikator
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 65 str. S198-S199
WoS-ID:	000325359201454
URI:	https://enauka.gov.rs/handle/123456789/819606
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

13
WEB OF SCIENCE^TM

Pronađi DOI

Pronalaženje DOI u servisu CrossRef-u na osnovu meta-podataka u zapisu. Prikazaće se DOI (i metapodaci) čiji se podaci najviše poklapaju. OPREZ - to ne mora biti ta publikacija.

Google Scholar^TM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.